Fundz

Acura Stem reported raising $400,000 in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATENov 22, 2022$400K of $3.5M raised

Amount Raised

$400,000

$400,000 sold, per SEC Form D (first sale Nov 11, 2022)

Round Type

Seed

MonroviaBiotechnology

Quick answer

AcuraStem Inc raised $400,000 in a Seed round, dated November 11, 2022. AcuraStem Inc is based in Monrovia, California, United States.

How much did AcuraStem Inc raise?
AcuraStem Inc raised $400,000 in a Seed round on November 11, 2022.
What does AcuraStem Inc do?
AcuraStem (acurastem.com) is a near-to-clinic, patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative diseases—including sporadic ALS and FTD.
Where is AcuraStem Inc based and how big is it?
AcuraStem Inc is based in Monrovia, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as AcuraStem Inc that raised within 45 days of this round, from Fundz verified event records.

  • Mytide Therapeutics, Inc. raised $7.1M on December 23, 2022.
  • Aliada Therapeutics raised $32M on December 23, 2022.
  • GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.
  • PVmed raised $14M (Series A) on December 23, 2022.
  • LIPOGEMS raised $13M (Funding Round) on December 23, 2022.
  • Ensoma raised $79M on December 23, 2022.

Who to call at AcuraStem Inc, and when

A new round usually means AcuraStem Inc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AcuraStem Inc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AcuraStem Inc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AcuraStem Inc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AcuraStem Inc

Location

605 E. HUNTINGTON DR., SUITE 103

Monrovia, California, United States

About

AcuraStem (acurastem.com) is a near-to-clinic, patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative diseases—including sporadic ALS and FTD. Enabled by our ground-breaking iNeuroRx® technology platform - AcuraStem has discovered and is now advancing drug candidates that promise to strongly impact disease progression for most patients, including those for whom the genetic cause of their disease is unknown (i.e. sporadic ALS and FTD patients). The causes of neurodegenerative diseases are complex, and genetically defined forms of disease (e.g. C9ORF72-ALS and FTD) only account for a small percentage of cases. Thus, many scientists didn’t believe it was possible to develop a single effective treatment that could work broadly for all patients. But AcuraStem has shown with its extremely promising therapeutic programs for ALS and FTD that it can be done. Go to acurastem.com to find out more

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AcuraStem Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AcuraStem Inc's next move

See what Strategic adds

AcuraStem Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.